1 of 38

NEUROPATHIC PAIN

DR NAEMAH BINTI SHARIFUDDIN

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

2 of 38

INTRODUCTION

  • Neuropathic pain is defined as 'pain caused by a lesion or disease of the somatosensory nervous system’1
  • Central Neuropathic pain – lesion/disease in the central somatosensory system
  • Peripheral Neuropathic pain - lesion to the peripheral somatosensory system
  • Management of neuropathic pain is difficult - difficulty in identifying the nature and exact location of a lesion or health condition causing the neuropathic pain

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

3 of 38

INTRODUCTION

  • No gold standard, or sets of biomarkers that can document neuropathic pain
  • High index of suspicion is required for the diagnosis of neuropathic pain as it can develop slowly over time
  • Incidences reported:
    • 40 per 100,000 for post herpetic neuralgia
    • 27 per 100,000 for trigeminal neuralgia
    • 15 per 100,000 for Diabetic Polyneuropathy

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

4 of 38

DIAGNOSIS

  • Usually described as burning, painful, cold or electric shocks
  • Maybe associated with tingling, pins & needles, numbness or itching
  • Pain will affect function, sleep, mood, work, and family and social life
  • Important to assess beliefs about the pain and helpful or non-helpful self management strategies – will influence the pain and its management
  • Use of screening tools help diagnosis and useful during follow up

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

5 of 38

MANAGEMENT

  • Goal of management are:
    • To reduce or eliminate pain
    • Improve physical functioning
    • Reduce physiological distress
    • Improve overall quality of life

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

6 of 38

DIAGNOSTIC SCREENING TOOLS

  • Validated diagnostic screening tools may be useful:
    • Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)
    • Self reported LANSS (S-LANSS)
    • Neuropathic Pain Questionnaire (NPQ)
    • Douleur Neuropathique en 4 (DN4) questions
    • painDETECT
    • ID-Pain

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

7 of 38

LANSS PAIN SCALE

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

8 of 38

S-LANSS – patient self score

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

9 of 38

Score of ≥ 4 indicates neuropathic pain

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

10 of 38

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

11 of 38

Pain DETECT

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

12 of 38

EXAMINATION

  • Sensory examination – light touch, temperature, painful stimulus, vibration & proprioception
  • Compare both sides and grade as normal, decreased or increased
  • Motor testing – tone, strength, reflexes and coordination
  • Autonomic changes – colour, temperature, sweating and swelling

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

13 of 38

INVESTIGATIONS

  • Imaging (CT or MRI) – may be required to exclude nerve entrapment and disc pathology
  • Nerve conduction studies or electromyography are useful if large myelinated axonal damage is suspected
  • Routine blood test to exclude differential diagnoses:
    • FBC, ESR, glucose, creatinine, ALT, vitamin B12, serum protein immunoelectrophoresis and thyroid function

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

14 of 38

Common Neuropathic Pain seen in Primary Care

Condition

Cause

Diabetic Polyneuropathy (DPN)

Metabolic disease

Trigeminal neuralgia (TN)

Peripheral nerve compression/ idiopathic

Post herpetic neuralgia

(PHN)

Infection

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

15 of 38

DIABETIC POLYNEUROPATHY (DPN)

  • It is estimated 6-51% of diabetics have DPN
  • It is not possible to predict which patients will develop DPN
  • Affects both autonomic and peripheral nervous system
  • Peripheral nerve involvement – tingling & burning in hands and feet, may have ‘electric shock, hyperalgesia or allodynia
  • Clinical features– reduced sensation to light touch and vibration, reduced ankle jerks and mild weakness
  • ‘glove & stocking’ pattern of sensory loss
  • Differential diagnoses – neurotoxicity (meds or heavy metals), nutritional deficiencies, alcohol related neuropathy, thyroid or electrolyte disorders, nerve entrapment or inflammatory/congenital causes

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

16 of 38

DIABETIC POLYNEUROPATHY (DPN) - MANAGEMENT

  • Primary prevention – early diagnosis, exclusion of underlying causes
  • good glycemic control and lifestyle changes to delay progression and prevent complications
  • Current evidence for pharmacotherapy supports use of tricyclic antidepressants (TCA), serotonin-norepinephrine reuptake inhibitors (SNRIs) such as duloxetine/venlafaxine, gabapentin, pregabalin, tramadol, morphine and oxycodone
  • Appropriate footwear and podiatry care

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

17 of 38

POSTHERPETIC NEURALGIA (PHN)

  • Pain that last for more that 3/12 after the onset of herpes zoster (HZ) infection
  • Pain intensity can be mild, moderate or severe
  • Incidence is unknown but is uncommon in those aged less than 50yrs
  • Some patients with recurrent HZ infection do not develop PHN
  • Symptoms – sharp or burning pain or ache in dermatomal distribution
  • Affected skin may be sensitive to light touch or may have shooting pain that can be excruciating
  • Examination may reveal past vesicular rash in dermatomal distribution and hyperalgesia or allodynia

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

18 of 38

POSTHERPETIC NEURALGIA (PHN) - MANAGEMENT

  • Prevention and management of acute HZ infection
    • Paediatric vaccination reduces varicella infection with IgG antibody formation
    • Adult vaccination stimulates T-cell mediated immunity and may reduce HZ and PHN
  • Treating symptoms of PHN
    • Early antiviral therapy shown to reduce the severity and duration of acute HZ infection
    • Corticosteroid and oxycodone reduce pain during acute infection
    • Pregabalin, gabapentin, TCA, lidocaine 5% patch, and capsaicin cream may reduce PHN pain
    • Complimentary combinations of pharmacological agents are more effective than monotherapy

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

19 of 38

TRIGEMINAL NEURALGIA

  • Sudden severe brief episodes of recurrent stabbing pain in the distribution of one or more branches of the trigeminal nerve
  • Majority presents unilaterally
  • Women twice as likely affected than men and more common in the 50+ years age group
  • Can affect 1,2 or all 3 branches mostly affecting the maxillary and mandibular branches – only 2% affecting ophthalmic branch

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

20 of 38

TRIGEMINAL NEURALGIA

  • Symptoms – jaw pain that maybe aggravated by chewing, swallowing, talking, touch or consuming hot/cold food or drinks
  • Pain can be triggered by shaving or wind blowing across face
  • Severe paroxysm are described as ‘shooting’, ’sharp’ or electric like.
  • Pathognomonic feature – trigger zones in the distribution of affected nerve
  • An attack lasts between 10secs to 2 minutes followed by refractory period
  • Weight loss, insomnia and reduced functioning may occur
  • Examination may see allodynia or hyperalgesia at the area

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

21 of 38

TRIGEMINAL NEURALGIA

  • Common cause is compression of the sensory ganglion of trigeminal nerve or its branches by a blood vessel
  • Management is by using carbamazepine 200-400mg/day, pain relief is seen in one of every 2 cases.
  • Gabapentin, pregabalin, topiramate and older anticonvulsant have been used in refractory cases.
  • Surgical treatment (decompressive or ablative) may be needed.

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

22 of 38

COMPLEX REGIONAL PAIN SYNDROME

  • Rarely seen in primary care
  • Diagnosis is based on cluster of clinical criteria affecting the somatosensory and autonomic nervous system
  • Early recognition in primary care, implementation of treatment and referral to pain service will help minimize function loss, chronicity and disability

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

23 of 38

CASE DISCUSSIONS

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

24 of 38

CASE SCENARIO 1

  • 60 years old lady, complaining of constant burning sensation over both feet past 2 months
  • What other history would you want?
    • More about the pain (onset, severity, characteristic)
    • Past medical history
    • Physical examination

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

25 of 38

CASE SCENARIO 1

  • Pain score is 5/10, disturbing sleep, burning sensation started mildly 2 months ago and increasing in intensity, associated with pins and needles feeling.
  • Underlying T2DM past 10 years
  • On examination of the feet:
    • Dryness of the skin with multiple hyper-pigmented lesions seen
    • Reduced sensation to pinprick and light touch up to mid-shin
    • Reduced vibratory sense (128 hz tuning fork) and monofilament test

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

26 of 38

DIAGNOSTIC TOOL: DN4 NEUROPATHIC PAIN DIAGNOSTIC QUESTIONNAIRE

4

X

X

X

X

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

27 of 38

CASE SCENARIO 1

DIAGNOSIS?

    • Diabetic peripheral neuropathy

The goals of management in neuropathic pain are:

    • to reduce pain
    • improve physical functioning
    • reduce physiological distress
    • improve overall quality of life

Best results with multidisciplinary approach

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

28 of 38

MANAGEMENT

  • TREATMENT TO REDUCE PAIN
    • First line:
    • Tricyclic Antidepressant – T. Amitriptyline 25mg ON
    • T. Gabapentin 300mg OD to 300mg tds
    • Duloxetine 30mg/day increasing to 60mg bd
    • Pregabalin
    • Second line:
      • Tramadol or oxycodone

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

29 of 38

DRUG

RECOMMENDED FOR

STARTING DOSE

DOSE TITRATION (IF NECESSARY)

MAXIMUM DOSE

DURATION OF ADEQUATE TRIAL

ANTICONVULSANT

Pregabalin

PHN (1st line)

DPN (1st line)

TN (2nd line)

150mg/day as 75mg bid

increase to 300mg daily after 3-7 days, then by 150mg/day every 3-7 days as tolerated

600mg daily (300mg bid

4 weeks

Gabapentin

PHN (1st line)

DPN (1st line)

TN (2nd line)

Day 1, 300mg at bedtime

Day 2, 300mg bid

Day 3, 300mg tid

increase by 300mg tid every 1-7 days as tolerated

3,600mg daily (1,200mg tid)

3-8 weeks for titration plus 2 weeks at maximum tolerated dose

ANTI DEPRESSANT

amitriptyline

PHN (1st line)

DPN (1st line)

TN (2nd line)

10-25mg daily at bedtime

increase by 10-25mg weekly

up to 50mg

3 months at maximum tolerated dosage

nortriptyline, despiramine

 

PHN (1st line)

DPN (1st line)

TN (2nd line)

10-25mg daily at bedtime

increase by 25mg dly every 3-7 days as tolerated

150mg dly

6-8 weeks with at least 2 weeks at maximum tolerated dosage

duloxetine

DPN (1st line)

30mg/day

increase to 60mg/day after 1 wk

60mg twice a day

4 weeks

OPIOIDS

morphine, oxycodone

conditions with mixed nociceptive and neuropathic pain

10-15mg morphine q4hr or as needed (equianalgesic dosage for other opioid analgesics)

after 1-2 wks convert total dosage to long-acting opioid analgesic and continue short-acting medication as needed

no maximum dosage with careful titration

4-6 weeks

tramadol

PHN (2nd line)

DPN (2nd line)

50mg qd or bid

increase by 50-100mg dly in divided doses every 3-7days as tolerated

400mg OD (100mg QID); 300mg OD in patients >75 years

4 weeks

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

30 of 38

OTHER MANAGEMENT

  • Diabetic control – to reduce further development of DPN
  • Skin care and foot care to prevent infections
  • Footwear may need to be revised indoor and outdoor

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

31 of 38

CASE SCENARIO 2

  • 65 year old man complains of burning, tingling and itching sensation over his abdomen for the past 1 week
  • What other history would you want?
    • More about the pain (onset, severity, characteristic)
    • Past medical history
    • Physical examination

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

32 of 38

CASE SCENARIO 2

  • He had history of herpes zoster infection a month ago over the same area
  • Pain Initially mild but became constant with pain score 6/10
  • Burning in nature and pain worst when his skin came in contact with his clothing
  • On examination, hyper pigmented scar seen over his right upper quadrant of the abdomen (T9–T10)

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

33 of 38

DIAGNOSTIC TOOL: DN4 NEUROPATHIC PAIN DIAGNOSTIC QUESTIONNAIRE

4

X

X

X

X

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

34 of 38

CASE SCENARIO 2

  • DIAGNOSIS
    • Post herpetic neuralgia

  • MANAGEMENT

The goals of management in neuropathic pain are:

    • to reduce pain
    • improve physical functioning
    • reduce physiological distress
    • improve overall quality of life

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

35 of 38

PAIN RELIEF

  • First line:
    • Pregabalin 75mg bd up to 300mg bd
    • T. Gabapentin 300mg OD up to 1,200mg tds ( titrate up to max tolerated dose)
    • Amitriptyline 25mg ON up to 50mg ON

Other management:

    • Explain to patient no ongoing damage
    • Relaxation technique

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

36 of 38

DRUG

RECOMMENDED FOR

STARTING DOSE

DOSE TITRATION (IF NECESSARY)

MAXIMUM DOSE

DURATION OF ADEQUATE TRIAL

ANTICONVULSANT

Pregabalin

PHN (1st line)

DPN (1st line)

TN (2nd line)

150mg/day as 75mg bid

increase to 300mg daily after 3-7 days, then by 150mg/day every 3-7 days as tolerated

600mg daily (300mg bid

4 weeks

Gabapentin

PHN (1st line)

DPN (1st line)

TN (2nd line)

Day 1, 300mg at bedtime

Day 2, 300mg bid

Day 3, 300mg tid

increase by 300mg tid every 1-7 days as tolerated

3,600mg daily (1,200mg tid)

3-8 weeks for titration plus 2 weeks at maximum tolerated dose

ANTI DEPRESSANT

amitriptyline

PHN (1st line)

DPN (1st line)

TN (2nd line)

10-25mg daily at bedtime

increase by 10-25mg weekly

up to 50mg

3 months at maximum tolerated dosage

nortriptyline, despiramine

 

PHN (1st line)

DPN (1st line)

TN (2nd line)

10-25mg daily at bedtime

increase by 25mg dly every 3-7 days as tolerated

150mg dly

6-8 weeks with at least 2 weeks at maximum tolerated dosage

duloxetine

DPN (1st line)

30mg/day

increase to 60mg/day after 1 wk

60mg twice a day

4 weeks

OPIOIDS

morphine, oxycodone

conditions with mixed nociceptive and neuropathic pain

10-15mg morphine q4hr or as needed (equianalgesic dosage for other opioid analgesics)

after 1-2 wks convert total dosage to long-acting opioid analgesic and continue short-acting medication as needed

no maximum dosage with careful titration

4-6 weeks

tramadol

PHN (2nd line)

DPN (2nd line)

50mg qd or bid

increase by 50-100mg dly in divided doses every 3-7days as tolerated

400mg OD (100mg QID); 300mg OD in patients >75 years

4 weeks

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

37 of 38

PROGRESS OF PATIENT

  • Pain reduced with gabapentin given
  • Pain score 3/10
  • Occasionally burning sensation still felt
  • Able to wear clothes and continue with normal daily activity

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA

38 of 38

THANK YOU

PAIN FREE PROGRAMME I KEMENTERIAN KESIHATAN MALAYSIA I BAHAGIAN PEMBANGUNAN KESIHATAN KELUARGA